RECRUITING

The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

Description

The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children aged 4-11 years in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?

Study Overview

Study Details

Study overview

The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children aged 4-11 years in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?

Testing the Effectiveness and Implementation of an Evidence-Based Maternal Depression Treatment in an Urban Pediatric Asthma Clinic

The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

Condition
Asthma in Children
Intervention / Treatment

-

Contacts and Locations

Washington

Children's National Hospital, Washington, District of Columbia, United States, 20010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary caregiver of the child with asthma seen at the community-based asthma clinic
  • * Female (self-identified)
  • * Black (self-identified)
  • * ≥ 18 years of age
  • * English-speaking
  • * PHQ-9 ≥ 10 during standardized screening at the child with asthma's clinic visit
  • * Ages 4-11 years
  • * Publicly insured
  • * Physician-diagnosed persistent asthma
  • * Acutely suicidal (high risk on the C-SSRS at child's asthma clinic visit)
  • * Bipolar disorder or mania
  • * Schizophrenia
  • * Current substance abuse/dependence
  • * Current serious physical intimate partner violence (IPV)
  • * Significant medical co-morbidity (e.g., disorders of the cardiorespiratory system, significant developmental delay, diabetes, seizure disorder, and sickle cell disease)
  • * Enrolled in another intervention with a behavioral component and/or novel asthma therapeutics

Ages Eligible for Study

4 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Children's National Research Institute,

Rachel Margolis, PhD, MSW, PRINCIPAL_INVESTIGATOR, Children's National Research Institute

Study Record Dates

2027-04-30